BRIEF-Merrimack stockholders approve Onivyde, generic Doxil sale to Ipsen
March 30, 2017 at 12:14 PM EDT
* Merrimack stockholders approve sale of Onivyde and generic version of Doxil to Ipsen for up to $1.025 billion
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.